Femasys (FEMY) Free Cash Flow Growth (1y) (2021 - 2026)
Femasys (FEMY) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.18 Bn | 121.97 Bn | 1.96 Bn | 44.68% |
| 2 | Becton Dickinson | 44.82 Bn | 44.00 Bn | 2.15 Bn | 271.70% |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | - |
| 4 | Medline | 32.89 Bn | 30.65 Bn | 1.84 Bn | -45.89% |
| 5 | Resmed | 29.34 Bn | 27.68 Bn | 890.98 Mn | -6.70% |
| 6 | West Pharmaceutical Services | 23.37 Bn | 22.94 Bn | 329.20 Mn | -20.71% |
| 7 | Solventum | 14.11 Bn | 13.54 Bn | 1.10 Bn | -241.25% |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn | 432.60% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 339.10% |
| 10 | Femasys | 14.28 Mn | 8.89 Mn | - | 13.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.15% |
| Dec 31, 2025 | 16.53% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | 1.38% |
| Mar 31, 2025 | -4.95% |
| Dec 31, 2024 | -68.18% |
| Sep 30, 2024 | -104.05% |
| Jun 30, 2024 | -60.80% |
| Mar 31, 2024 | -74.39% |
| Dec 31, 2023 | -4.02% |
| Sep 30, 2023 | -4.88% |
| Jun 30, 2023 | -9.77% |
| Mar 31, 2023 | 7.58% |
| Dec 31, 2022 | -25.15% |
| Sep 30, 2022 | -39.02% |
| Jun 30, 2022 | 6.54% |
| Mar 31, 2022 | -147.65% |
| Dec 31, 2021 | -86.19% |
| Sep 30, 2021 | -129.29% |